Daewoong Pharmaceutical Co. Ltd.
Clinical trials sponsored by Daewoong Pharmaceutical Co. Ltd., explained in plain language.
-
New version of ovarian cancer drug tested in 40 patients
Disease control Recruiting nowThis study tests if a new version of the drug olaparib (DWZ2501) works the same as the current version (DWC202510) in people with advanced ovarian cancer linked to a BRCA gene mutation. About 40 adults who are already stable on olaparib will take both versions at different times …
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Can OLMETEC tame nighttime blood pressure? large korean study aims to find out
Disease control Recruiting nowThis study looks at how well the blood pressure drug OLMETEC (or OLMETEC Plus) controls blood pressure at night in Korean adults with mild (stage 1) hypertension. About 12,000 participants will take the drug as part of their normal care and have their blood pressure monitored ove…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
Healthy volunteers needed to test new drug combinations
Knowledge-focused Recruiting nowThis early-phase study is testing the safety and how the body processes three experimental drugs (DWJ1622, DWC202313, and DWC202314) in 40 healthy adults. Participants take a single dose on an empty stomach and are monitored closely. The goal is to gather important safety and dru…
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC
-
Healthy volunteers sought for Early-Stage drug combo study
Knowledge-focused Recruiting nowThis early-stage study is testing how safe three experimental drugs (DWJ1622, DWC202313, and DWC202314) are and how they move through the body. It involves 36 healthy adults who will take the drugs after a meal. The goal is to gather basic safety and drug-level information, not t…
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC